Skip to main content
Fig. 1 | BMC Ophthalmology

Fig. 1

From: Increased serum concentration of netrin-1 after intravitreal bevacizumab injection: is it a compensatory mechanism to counteract drug side effects?

Fig. 1

a Vascular endothelial growth factor (VEGF) concentrations at baseline, 1 week, and 1 month after bevacizumab (BCZ) injection in the non-proliferative diabetic retinopathy (NPDR) and proliferative diabetic retinopathy (PDR) groups. b Netrin-1 concentrations before and 1 week and 1 month after bevacizumab (BCZ) injection in the non-proliferative diabetic retinopathy (NPDR) and proliferative diabetic retinopathy (PDR) groups

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us